A series of cancer diagnosis 'one-stop shops' is being rolled out across England, with digital health technology playing an important role in hastening diagnosis.
Celgene’s chief operating officer and inflammatory diseases guru Scott Smith has quit the company, in the aftermath of the FDA’s rejection of a key multiple sclerosis pill, and a late-stage
